Randomized Controlled Trial

. 2014 Jul;168(1):23-9.e2.

doi: 10.1016/j.ahj.2014.03.021. Epub 2014 Apr 5.

Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial

Rury R Holman¹, Mary A Bethel², Juliana C N Chan³, Jean-Louis Chiasson⁴, Zoë Doran², Junbo Ge⁵, Hertzel Gerstein⁶, Yong Huo⁷, John J McMurray⁸, Lars Ryden⁹, Winitha Liyanage², Stefan Schröder¹⁰, Michal Tendera¹¹, Michael J Theodorakis², Jaakko Tuomilehto¹², Wenying Yang¹³, Dayi Hu¹⁴, Changyu Pan¹⁵; ACE Study Group

Collaborators, Affiliations

Collaborators

ACE Study Group:
R R Holman, C Y Pan, D Y Hu, J Chan, J-L Chiasson, Z Doran, J Ge, H Gerstein, Y Huo, Z Lang, J McMurray, L Ryden, S Schröder, M Tendera, J Tuomilehto, W Yang, J Rouleau, J Collier, S Pocock, E Standl, K Swedberg, J Weng, D Zhao, D Wang, M Petrie, E Connelly, P Jhund, M MacDonald, R Myles, N Sattar, M Fisher, J Petrie, Y Sun, Y Wei, W Xu, N Groves, W Liyanage, J Tang, M J Theodorakis, J Bi, H Feng, R Hu, P Liu, M Wei, X Wei, X Yang, J Yin, J Zhou, L Deng, D Hu, Q Hua, T Hu, H Li, H Li, J Lu, C Ma, X Ma, L Pi, L Shi, B Wang, M Wang, G Wei, M Yang, W Yang, L Zhang, S Zhang, Y Zhou, H Lei, R Liao, X Mei, Q She, J Tan, M Xia, L Chen, X Pu, Y Wang, Q Xie, S Xiong, C Chen, J Chen, Y Dong, Z Li, C Wu, S Zhou, Y Yuan, W Zhou, R Kuang, J Wei, Z Zhao, G Zhong, L Wu, H Fang, H Li, L Kong, G Liu, Y Hao, C Wang, X Li, L Wang, P Dong, H Liu, X Liu, S Zhang, Y Zhao, J Chan, Risa Ozaki, Y Gu, Y Liao, X Su, D Wang, H Wang, B Yang, Y Guo, T Yang, Y Han, X Lin, R Zhao, R Bian, Y Guo, H Zhang, B Hasimu, H Jin, P Liu, K Lv, Y Tao, C Xu, B Xu, Z Yang, J Yu, G Zhang, L Hong, L Hu, J Li, B Liu, P Yang, P Han, Y Jin, L Li, H Lin, J Liu, Z Li, G Wang, S Zhang, H Luan, M Song, L Xue, J Feng, F Gao, Y Hua, J Ye, Z Yuan, Z Hou, X Li, W Qi, G Su, Y Wang, S Zhang, B Wang, J Ge, X Guo, H Gong, S Gu, B He, Y Jiang, H Jin, Y Li, Q Liu, G Lu, J Ma, Y Qin, S Wu, Y Xu, X Chen, J Tang, J Wang, D Liu, X Chen, J Tao, Y Yan, T Zhang, D Li, X Du, X Guo, T Jiang, T Li, Z Li, J Lin, C Lu, S Zhao, S Zheng, K Li, Q Qui, B Tang, J Zhou, G Zhang, T Guo, H Zhang, F Shen, G Fu

Affiliations

¹ Diabetes Trials Unit, University of Oxford, Oxford, United Kingdom. Electronic address: rury.holman@dtu.ox.ac.uk.
² Diabetes Trials Unit, University of Oxford, Oxford, United Kingdom.
³ Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
⁴ CRCHUM, Department of Medicine, University of Montreal, Montreal, Canada.
⁵ Zhongshan Hospital, Fudan University, Shanghai, China.
⁶ Department of Medicine and Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.
⁷ Department of Cardiology, Peking University First Hospital, Beijing, China.
⁸ Institute of Cardiovascular & Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
⁹ Cardiology Unit, Karolinska University Hospital Solna, Stockholm, Sweden.
¹⁰ Bayer Healthcare, Bayer Pharma AG, Berlin, Germany.
¹¹ 3rd Division of Cardiology, Medical University of Silesia, Katowice, Poland.
¹² Centre for Vascular Prevention, Danube-University Krems, Krems, Austria; Diabetes Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland; King Abdulaziz University, Jeddah, Saudi Arabia.
¹³ China-Japan Friendship Hospital, Beijing, China.
¹⁴ People's Hospital of Peking University, Beijing, China.
¹⁵ Department of Endocrinology, People's Liberation Army General Hospital, Beijing, China.

PMID: 24952856
DOI: 10.1016/j.ahj.2014.03.021

Randomized Controlled Trial

Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial

Rury R Holman et al. Am Heart J. 2014 Jul.

. 2014 Jul;168(1):23-9.e2.

doi: 10.1016/j.ahj.2014.03.021. Epub 2014 Apr 5.

Authors

Collaborators

ACE Study Group:
R R Holman, C Y Pan, D Y Hu, J Chan, J-L Chiasson, Z Doran, J Ge, H Gerstein, Y Huo, Z Lang, J McMurray, L Ryden, S Schröder, M Tendera, J Tuomilehto, W Yang, J Rouleau, J Collier, S Pocock, E Standl, K Swedberg, J Weng, D Zhao, D Wang, M Petrie, E Connelly, P Jhund, M MacDonald, R Myles, N Sattar, M Fisher, J Petrie, Y Sun, Y Wei, W Xu, N Groves, W Liyanage, J Tang, M J Theodorakis, J Bi, H Feng, R Hu, P Liu, M Wei, X Wei, X Yang, J Yin, J Zhou, L Deng, D Hu, Q Hua, T Hu, H Li, H Li, J Lu, C Ma, X Ma, L Pi, L Shi, B Wang, M Wang, G Wei, M Yang, W Yang, L Zhang, S Zhang, Y Zhou, H Lei, R Liao, X Mei, Q She, J Tan, M Xia, L Chen, X Pu, Y Wang, Q Xie, S Xiong, C Chen, J Chen, Y Dong, Z Li, C Wu, S Zhou, Y Yuan, W Zhou, R Kuang, J Wei, Z Zhao, G Zhong, L Wu, H Fang, H Li, L Kong, G Liu, Y Hao, C Wang, X Li, L Wang, P Dong, H Liu, X Liu, S Zhang, Y Zhao, J Chan, Risa Ozaki, Y Gu, Y Liao, X Su, D Wang, H Wang, B Yang, Y Guo, T Yang, Y Han, X Lin, R Zhao, R Bian, Y Guo, H Zhang, B Hasimu, H Jin, P Liu, K Lv, Y Tao, C Xu, B Xu, Z Yang, J Yu, G Zhang, L Hong, L Hu, J Li, B Liu, P Yang, P Han, Y Jin, L Li, H Lin, J Liu, Z Li, G Wang, S Zhang, H Luan, M Song, L Xue, J Feng, F Gao, Y Hua, J Ye, Z Yuan, Z Hou, X Li, W Qi, G Su, Y Wang, S Zhang, B Wang, J Ge, X Guo, H Gong, S Gu, B He, Y Jiang, H Jin, Y Li, Q Liu, G Lu, J Ma, Y Qin, S Wu, Y Xu, X Chen, J Tang, J Wang, D Liu, X Chen, J Tao, Y Yan, T Zhang, D Li, X Du, X Guo, T Jiang, T Li, Z Li, J Lin, C Lu, S Zhao, S Zheng, K Li, Q Qui, B Tang, J Zhou, G Zhang, T Guo, H Zhang, F Shen, G Fu

Affiliations

¹ Diabetes Trials Unit, University of Oxford, Oxford, United Kingdom. Electronic address: rury.holman@dtu.ox.ac.uk.
² Diabetes Trials Unit, University of Oxford, Oxford, United Kingdom.
³ Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
⁴ CRCHUM, Department of Medicine, University of Montreal, Montreal, Canada.
⁵ Zhongshan Hospital, Fudan University, Shanghai, China.
⁶ Department of Medicine and Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.
⁷ Department of Cardiology, Peking University First Hospital, Beijing, China.
⁸ Institute of Cardiovascular & Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
⁹ Cardiology Unit, Karolinska University Hospital Solna, Stockholm, Sweden.
¹⁰ Bayer Healthcare, Bayer Pharma AG, Berlin, Germany.
¹¹ 3rd Division of Cardiology, Medical University of Silesia, Katowice, Poland.
¹² Centre for Vascular Prevention, Danube-University Krems, Krems, Austria; Diabetes Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland; King Abdulaziz University, Jeddah, Saudi Arabia.
¹³ China-Japan Friendship Hospital, Beijing, China.
¹⁴ People's Hospital of Peking University, Beijing, China.
¹⁵ Department of Endocrinology, People's Liberation Army General Hospital, Beijing, China.

PMID: 24952856
DOI: 10.1016/j.ahj.2014.03.021

Abstract

Patients with cardiovascular disease and impaired glucose tolerance are at increased risk of cardiovascular events and type 2 diabetes mellitus (T2DM). Lifestyle modification or pharmacological intervention can delay progression to T2DM, but there is no clear evidence that they reduce cardiovascular risk in this population. Acarbose, an α-glucosidase inhibitor that lowers postprandial blood glucose, has been shown to reduce T2DM risk by 25%, and possibly cardiovascular risk in impaired glucose tolerance subjects without cardiovascular disease.

PubMed Disclaimer

Cited by

Impact of the use of anti-diabetic drugs on survival of diabetic dialysis patients: a 5-year retrospective cohort study in Taiwan.
Hsiao PJ, Wu KL, Chiu SH, Chan JS, Lin YF, Wu CZ, Wu CC, Kao S, Fang TC, Lin SH, Chen JS. Hsiao PJ, et al. Clin Exp Nephrol. 2017 Aug;21(4):694-704. doi: 10.1007/s10157-016-1330-4. Epub 2016 Sep 6. Clin Exp Nephrol. 2017. PMID: 27599981
Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus.
Tahrani AA, Barnett AH, Bailey CJ. Tahrani AA, et al. Nat Rev Endocrinol. 2016 Oct;12(10):566-92. doi: 10.1038/nrendo.2016.86. Epub 2016 Jun 24. Nat Rev Endocrinol. 2016. PMID: 27339889 Review.
Cardiovascular Outcome Trials with Glucose-Lowering Drugs.
Thethi TK, Bilal A, Pratley RE. Thethi TK, et al. Curr Cardiol Rep. 2021 Jun 3;23(7):75. doi: 10.1007/s11886-021-01505-3. Curr Cardiol Rep. 2021. PMID: 34081215 Review.
Early effective intervention can significantly reduce all-cause mortality in prediabetic patients: a systematic review and meta-analysis based on high-quality clinical studies.
An X, Zhang Y, Sun W, Kang X, Ji H, Sun Y, Jiang L, Zhao X, Gao Q, Lian F, Tong X. An X, et al. Front Endocrinol (Lausanne). 2024 Mar 1;15:1294819. doi: 10.3389/fendo.2024.1294819. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38495794 Free PMC article.
Antidiabetic treatment with gliptins: focus on cardiovascular effects and outcomes.
Fisman EZ, Tenenbaum A. Fisman EZ, et al. Cardiovasc Diabetol. 2015 Sep 29;14:129. doi: 10.1186/s12933-015-0294-0. Cardiovasc Diabetol. 2015. PMID: 26415691 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial

Collaborators

Affiliations

Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial

Authors

Collaborators

Affiliations

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Miscellaneous

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Miscellaneous